In Pilot Study, OICR Aims to Validate PacBio RS for Targeted Sequencing of Cancer Patients

OICR plans to validate the machine and develop a framework for sequencing patient tumors that can help physicians make informed decisions about treatments or clinical trial placements.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.